Sanofi was one of three drug manufacturers to recently update its contract pharmacy restrictions in response to new state laws.
More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions
Views
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.